Patents for A61P 35 - Antineoplastic agents (221,099)
03/1991
03/22/1991WO1991004058A2 Treatment of conditions and disease
03/22/1991CA2042034A1 Treatment of conditions and disease
03/22/1991CA2025830A1 Pyrrolopyrimidines, their production and use
03/21/1991WO1991004259A1 Lipid a monosaccharide analog
03/21/1991WO1991003556A1 Recombinant product
03/20/1991EP0418143A1 Dicarboxylic acids derivatives containing a nitrogen or oxygen heteroring, process for their preparation and their use as medicines
03/20/1991EP0417999A1 Antiviral compounds
03/20/1991EP0417941A2 Use of a cyanine dye in an antitumor agent
03/20/1991EP0417870A2 Chelates for complexation of radioactive isotopes, their metal complexes and their use in diagnosis and therapy
03/20/1991EP0417803A1 [N-(gamma-glutamyl)glycyl] alanine derivatives
03/20/1991EP0417721A2 Novel peptidase and isomerase inhibitors
03/20/1991EP0417168A1 Antibodies to human mammary cell growth inhibitor and methods of production and use
03/20/1991CN1049973A Pharmaceutical composition having antitumor activity and preparation for its manufacture
03/20/1991CA2023813A1 Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4 - tetrahydroquinolinyl group having retinoid-like activity
03/19/1991US5001236 Benzothiazepines
03/19/1991US5001124 4-isoxazolecarboxamide derivatives
03/19/1991US5001112 Antitumor antibiotic kedarcidin
03/19/1991CA1281656C Process for treating metastasis of cancerous tumors
03/19/1991CA1281652C Readily absorbable pharmaceutical composition
03/16/1991WO1991004046A1 Gamma glutamyl transferases for treating diseases
03/16/1991WO1991004022A1 Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
03/16/1991CA2065157A1 Gamma glutamyl transferases for treating diseases
03/15/1991WO1991004268A1 [N-(η-GLUTAMYL)GLYCYL]ALANINE DERIVATIVES
03/15/1991CA2035458A1 ¬n-(û-glutamyl)glycyl|alanine derivatives
03/13/1991WO1991004320A1 The use of thioredoxin in the treatment of malignantly transformed cells in animals and man
03/13/1991EP0416502A1 A pharmaceutical composition having antitumor activity and preparation for its manufacture
03/13/1991EP0416396A2 Tetrasaccharides and process for their preparation
03/13/1991EP0416286A1 Sulfonylhydrazines and their use as antineoplastic agents and as antitrypanosomal agents
03/13/1991EP0416075A1 Acryloyl substituted pyrrole derivatives
03/13/1991EP0416033A1 Macrocyclic chelates and methods of use thereof.
03/13/1991EP0416024A1 SUBSTITUTED 6H-PYRIDO (4,3-b) CARBAZOLES
03/13/1991EP0415939A1 Platinum(ii) complexes, their preparation and use as anti-tumour agents
03/13/1991EP0415924A1 Regulation of cell proliferation and differentiation using peptides.
03/13/1991CN1049847A Process for preparation of phosphonomethylthioethoxypurines having antiviral activity
03/13/1991CA2065454A1 Use of thioredoxin in the treatment of malignantly transformed cells in animals and man
03/13/1991CA2025036A1 Dicarboxylic derivatives comprizing a nitrogenous or oxygenous heterocycle, process for their preparation and use as medicaments
03/12/1991WO1991003491A1 TGF-β PROTEIN COMPOSITIONS FOR INHIBITION OF CELL PROLIFERATION
03/12/1991US4999435 Cationic Surfactants, Drugs, Immunoassay
03/12/1991US4999369 Tetracyclic heterocyclic derivatives, pharmaceutical compositions and use
03/12/1991US4999345 Sulfonamide derivatives and drugs obtained therefrom
03/12/1991US4999339 Combination therapy of IL-2 and DTIC for the treatment of melanoma
03/12/1991US4999196 Compound DC-107 produced by Streptomyces sp.
03/12/1991CA2066228A1 Tgf-beta protein compositions for inhibition of cell proliferation
03/12/1991CA2025009A1 Antiviral compounds
03/12/1991CA2024661A1 Peptidase and isomerase inhibitors
03/12/1991CA2023595A1 Chelating agents for forming complexes with radioactive isotopes, metal complexes thereof and use thereof in diagnosis and therapy
03/12/1991CA1281327C Anti-tumour platinum complexes, their preparation and their use
03/12/1991CA1281288C Tumor therapy
03/09/1991WO1991003489A1 Structural alterations of the egf receptor gene in human gliomas
03/07/1991WO1991002753A1 Anticoagulant protein
03/07/1991WO1991002749A1 PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP) AND DIAGNOSTIC AND THERAPEUTIC USE THEREOF
03/07/1991WO1991002746A1 Therapeutic peptides
03/07/1991CA2065017A1 Peptides from gtpase-activating protein (gap) and diagnostic and therapeutic use thereof
03/07/1991CA2064896A1 Therapeutic peptides
03/07/1991CA2024523A1 Sulfonylhydrazines and their use as antineoplastic agents and as antitrypanosomal agents
03/06/1991EP0415731A2 Novel entities for cancer therapy
03/06/1991EP0415623A2 Toremifene or demethyltoremifene as hydroxytoremifene for the reversal of multidrug restistance of cancer cells against cytotoxic drugs
03/06/1991EP0415510A2 L-glutamic acid derivatives
03/06/1991EP0415453A2 Epipodophyllotoxin altroside derivatives
03/06/1991EP0415430A1 Stable solutions of mitomycin C
03/06/1991EP0415198A2 Ketophosphamidyl glycosides, process for their preparation and their use as pharmaceutical agents
03/06/1991EP0414807A1 Human mammary cell growth inhibitor and methods of production and use
03/05/1991US4997931 Epipodophyllotoxin glycosides
03/05/1991US4997913 pH-sensitive immunoconjugates and methods for their use in tumor therapy
03/05/1991US4997651 Pharmaceutical formulations
03/05/1991US4997645 Administering interferon and dipyridamole
03/05/1991CA2024485A1 Tetrasaccharides and process for their preparation
03/02/1991WO1991003482A1 New bis-platinum complexes as chemotherapeutic agents
03/02/1991WO1991003260A1 Antisense oligonucleotides to c-abl proto-oncogene
03/02/1991CA2065294A1 Antisense oligonucleotides to c-abl proto-oncogene
03/02/1991CA2024235A1 Epipodophyllotoxin altroside derivatives
03/02/1991CA2023995A1 Stable solutions of mitomycin c
02/1991
02/28/1991CA2009461A1 L-glutamic acid derivatives
02/27/1991EP0414206A2 2,4,6-Substituted phenol derivatives
02/27/1991EP0414007A2 A novel arginine deiminase, its manufacturing method and an anti-cancer agent containing this enzyme as an effective ingredient
02/27/1991EP0413908A2 Soluble extracellular fragment of the human IFN-beta 2/IL-6 receptor, its preparation and pharmaceutical compositions containing it
02/27/1991EP0413792A1 Products containing a lithium salt and a tumour necrosis factor.
02/27/1991EP0413762A1 Peptide analogs and their use as haptens to elicit catalytic antibodies
02/27/1991EP0413721A1 Human gm-csf variants
02/27/1991EP0413706A1 1,2,4-benzotriazine oxides as radiosensitizers and selective cytotoxic agents
02/26/1991US4996318 Amino-9,10-secosteroids useful for treating head injury, spinal cord trauma or stroke
02/26/1991US4996308 Derivatives with unsaturated substitutions for the 5'-hydroxymethyl group
02/26/1991US4996233 Method of reducing porphyrin toxicity using fatty acids
02/26/1991US4996207 Three new non-polyglutamatable deazaaminopterins
02/21/1991WO1991002342A1 Rotary display unit
02/21/1991WO1991002078A1 Tumour necrosis factor binding ligands
02/21/1991WO1991002062A2 C-erbb-2 external domain: gp75
02/21/1991WO1991001994A1 11β-SUBSTITUTED 16α,17α-METHYLENE-ESTRA-4,9-DIENE-3-ONES
02/21/1991WO1991001982A1 Discodermolide compounds, compositions containing same and methods of preparation and use
02/21/1991WO1991001975A1 Cycloalkylenazoles, process for preparing them, pharmaceutical preparations containing them and their use to manufacture drugs
02/21/1991WO1991001958A2 11β-ARYL-GONA-4,9-DIEN-3-ONES
02/21/1991WO1991001744A2 Uses of interleukin-4 and method for purifying it
02/21/1991WO1991001727A2 Method of detection and treatment of malignant and non-malignant lesions by photochemotherapy
02/21/1991WO1990011782A3 Immunoconjugates and prodrugs and their use in association for drug delivery
02/21/1991CA2064753A1 Uses of interleukin-4 and method for purifying it
02/20/1991EP0413622A1 Albumin derivatives with therapeutic functions
02/20/1991EP0413526A2 Process for preparing 2-deoxy-2, 2-difluoroxylose analogs and intermediates therefor
02/20/1991EP0413383A1 Mutants of human interleukin-3
02/20/1991CN1049353A Cyclic neurokinin a antagonists
02/19/1991WO1991002750A1 Novel inhibitors of thrombin